Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Tue, 09/29/15 - 09:16 am
Contrave
Takeda
Orexigen
obesity
Novo Nordisk: Has This Company Solved The Anti-Obesity Sector Woes?
Seeking Alpha
Tue, 09/29/15 - 08:58 am
Novo Nordisk
Saxenda
obesity
Canada
Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?
Motley Fool
Sat, 09/19/15 - 09:14 am
Orexigen
Europe
drug launches
obesity
Mysimba
Contrave
Novo Nordisk Launches Obesity Medication In Canada - How Did That Happen?
Seeking Alpha
Mon, 09/14/15 - 10:55 am
Novo Nordisk
obesity
Saxenda
Canada
drug launches
Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
Yahoo
Wed, 09/9/15 - 08:05 am
Zafgen
beloranib
clinical trials
obesity
diabetes
Arena: Belviq Advertising Slips - Sales Continue To Slip As Well
Seeking Alpha
Fri, 09/4/15 - 10:26 am
Arena
Belviq
obesity
drug ads
Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears
WSJ Online
Tue, 09/1/15 - 06:34 pm
Amgen
diabetes
obesity
Marijuana Gains Traction In Fight Against Diabetes And Obesity
Yahoo/Benzinga
Tue, 08/25/15 - 08:19 am
Medical Marijuana
obesity
diabetes
GW Pharma
Boehringer takes a neuroscience approach to obesity with latest deal
Fierce Biotech
Thu, 08/13/15 - 02:46 pm
obesity
Boehringer Ingelheim
Circuit Therapeutics
Can a dwindling rep tally keep Vivus' obesity med in the game?
Fierce Pharma Marketing
Mon, 08/3/15 - 04:52 pm
Vivus
obesity
drug reps
Qsymia
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Seeking Alpha
Mon, 06/22/15 - 12:49 pm
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
BioPharma Dive
Mon, 06/8/15 - 11:03 am
Orexigen
Takeda
Actavis
obesity
generics
Contrave
Zogenix says former obesity drug reduced seizures in study
Yahoo/Reuters
Wed, 05/27/15 - 12:46 pm
Zogenix
obesity
seizures
fenfluramine
Dravet syndrome
Novo Nordisk executive fuels firm's new obesity fight
Medical Marketing and Media
Tue, 05/26/15 - 10:46 am
Novo Nordisk
obesity
Saxenda
Jesper Høiland
Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate
Seeking Alpha
Tue, 05/26/15 - 09:57 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Belviq
Contrave
Weight loss: 1st commercial implant of EnteroMedics' Maestro device
Mass Device
Thu, 05/21/15 - 10:16 am
EnteroMedics
obesity
devices
Maestro implant
Arena: Belviq Sales Flattening Out - Is It Sector Saturation?
Seeking Alpha
Wed, 05/20/15 - 10:31 am
Arena
Belviq
obesity
Orexigen Safety Study for Diet Pill Ends due to Premature Data Disclosure
WSJ Pharmalot
Tue, 05/12/15 - 04:20 pm
Orexigen
Contrave
obesity
Vivus - Qsymia Script Sales Flat Again - Should Vivus Concentrate On Stendra?
Seeking Alpha
Sat, 05/9/15 - 12:19 pm
Vivus
Qsymia
Stendra
obesity
erectile dysfunction
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »